daratumumab in the treatment of heavily pretreated immune-mediated ttp
Published 2 months ago • 74 plays • Length 2:00Download video MP4
Download video MP3
Similar videos
-
3:57
daratumumab in the treatment of mm with high-risk cytogenetics
-
5:07
daratumumab in the management of al amyloidosis
-
1:53
exploring daratumumab as a treatment option for patients with t-all
-
1:28
campus all updates: the safety and efficacy of daratumumab for the treatment of all
-
1:48
a phase ii study of daratumumab and pomalidomide in previously treated patients with al amyloidosis
-
1:20
phase ii study investigating the efficacy of daratumumab in patients with stage 3b al amyloidosis
-
28:08
dr. gaby hobbs, md: diagnosis and initial treatment options for et, pv & mf
-
55:34
clinical trial updates for physicians
-
3:53
the benefits of hyperbaric oxygen therapy (hbot)
-
1:19
the potential of caplacizumab in the treatment of attp
-
0:58
dara-rvd in the treatment of hr-smm: an ongoing phase ii trial
-
2:05
alnuctamab: improved route of administration and optimized dose level & dosing schedule
-
3:07
daratumumab-based frontline therapy in al amyloidosis: real-world mayo clinic experience
-
1:33
the current guidelines and therapies for tp53-mutated mds and aml
-
1:21
daratumumab with atra in r/r mm
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
1:54
fostamatinib and efgartigimod: novel agents in the treatment of itp
-
3:27
case study: daratumumab in a relapsed patient
-
4:13
daratumumab as maintenance therapy after autosct in patients with multiple myeloma
-
1:06
daratumumab and carfilzomib for al amyloid neuropathy
-
0:43
elm-2: qol and orr outcomes of odronextamab treatment for r/r fl
-
1:33
zamtocabtagene autoleucel for the treatment of patients with r/r dlbcl